COBAS 8000 E602 MODULE 05990378001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-02-10 for COBAS 8000 E602 MODULE 05990378001 manufactured by Roche Diagnostics.

Event Text Entries

[37885525] This event occurred in (b)(6). (b)(4). (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[37885526] A female of unknown reproductive age was initially found to have an elevated intact human chorionic gonadotropin + the subunit (hcgb) result of 822 iu/l, which could indicate the patient was approximately 4-5 weeks pregnant. This result was reported outside of the laboratory and a surgical abortion was performed on the patient as the patient stated they "did not wish for a pregnancy". The patient was stated to be in a center for refugees in (b)(6). Physicians at the location reported to the facility that the hcgb test was giving implausible results. Based on these reports, the patient sample was later repeated. Subsequent repeat testing of the patient sample revealed a result of 0. 311 iu/l accompanied by a data flag on (b)(6) 2016. The analyzer automatically repeated the sample on (b)(6) 2016, resulting with a final value of 0. 320 iu/l. The sample was also repeated at another site on an e602 analyzer, resulting as 0. 247 iu/l. While the patient stated the patient did not wish for a pregnancy, it has not been confirmed if the patient was actually pregnant at the time of the event. Clarification has been requested. Limited records do not show if another temporally separated hcgb value was available. No record of an ultrasound was available. It is unclear if any additional testing was done to confirm pregnancy prior to the procedure. The patient's current condition and other medical history have been requested but not provided. Typically, a confirmatory ultrasound is performed or the hcgb is repeated on the patient in order to demonstrate a viable, growing fetus prior to performing a surgical abortion. Due to the limited records available, it is unclear if this was done. If an ultrasound or a follow up hcgb was not done prior to the procedure, this represents a departure from the community standard of care. An elevated hcgb may also be seen after a recent spontaneously aborted fetus and the hcg level is decreasing to non-pregnant levels. The hcgb reagent lot number was 18742800. The reagent expiration date was asked for, but not provided. The field service representative checked the bead mixer adjustments and these were ok. He found that the bead mixer was dirty and he cleaned it. He cleaned the reagent pipettor and found the adjustments to be acceptable. He found a lot of crystallization at the tip of the sample probe and he cleaned the probe. He found the liquid level detection of the probe to be too low, so he adjusted it. He cleaned and adjusted all sipper probes. He ran performance testing.
Patient Sequence No: 1, Text Type: D, B5


[38421982] It has been clarified that the involved patient was not adversely affected. The patient received the initial results on (b)(6) 2016 and went to the abortion clinic. The abortion clinic then advised the patient to wait for one week before starting an abortion procedure and the patient did wait. On (b)(6) 2016, the treating physician was informed that the initial results were not correct. The patient was then directly informed that she was not pregnant and an abortion procedure was not initiated.
Patient Sequence No: 1, Text Type: N, H10


[39437240] A specific root cause could not be determined based on the provided information. Observed contamination on the mixer could cause a contamination or blockage of the analyzer fluidics. The origin of the contamination could not be determined.
Patient Sequence No: 1, Text Type: N, H10


[40665361] The field service representative replaced seals and the mixer on the analyzer.
Patient Sequence No: 1, Text Type: N, H10


[41362778] The field service engineer ran performance testing and this failed. He adjusted the photomultiplier tube voltage and then successfully ran a blank cell calibration. After this, calibrations and controls were okay.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2016-00132
MDR Report Key5427195
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-02-10
Date of Report2016-03-28
Date of Event2016-01-04
Date Mfgr Received2016-01-15
Date Added to Maude2016-02-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1HITACHI HIGH TECH CORP.
Manufacturer Street882 ICHIGE HITACHINAKA NA
Manufacturer CityIBARAKI 312-8504
Manufacturer CountryJA
Manufacturer Postal Code312-8504
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Sequence Number: 0

Brand NameCOBAS 8000 E602 MODULE
Generic NameIMMUNOCHEMISTRY ANALYZER
Product CodeNAL
Date Received2016-02-10
Model NumberNA
Catalog Number05990378001
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Eval'ed by MfgrR
Device Sequence No0
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457

Device Sequence Number: 1

Brand NameCOBAS 8000 E602 MODULE
Generic NameIMMUNOCHEMISTRY ANALYZER
Product CodeJJE
Date Received2016-02-10
Model NumberNA
Catalog Number05990378001
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device Availability*
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.